To address the molecular mechanisms underlying the noted upregulation and oncogenic role of PSG9 in breast cancer cells, we analyzed the promoter sequence of the human PSG9 gene within 1‐kb region upstream from the transcriptional start site. This evidence concerns the gene PSG9 and breast cancer.